HealthcareServices

Antimicrobial Resistance (AMR) Genotyping Panels Industry Growth Insights: Revenue Forecast to 2030

February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the antimicrobial resistance (amr) genotyping panels market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Antimicrobial Resistance (AMR) Genotyping Panels Market covering 2026–2035?

The antimicrobial resistance (amr) genotyping panels market has seen substantial growth in recent years. It is anticipated to expand from $1.45 billion in 2025 to $1.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.4%. Key drivers contributing to its past growth include the escalating prevalence of antimicrobial resistance, an increase in hospital-acquired infections, the development of molecular diagnostic capabilities, a rising awareness regarding resistance monitoring, and the accessibility of advanced genotyping technologies.

The market for antimicrobial resistance (amr) genotyping panels is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $2.81 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.1%. This projected growth throughout the forecast period stems from factors such as heightened investments in infectious disease diagnostics, a growing need for swift point-of-care testing, the broadening scope of genomic epidemiology programs, the increasing incorporation of amr data analytics, and a greater regulatory emphasis on resistance surveillance. Key trends expected during the forecast period involve a greater uptake of multiplex resistance detection panels, an increased application of rapid molecular diagnostics, the expanding integration of genomic surveillance tools, the broadening of hospital-based amr testing, and an intensified focus on identifying resistance early.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30196&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Antimicrobial Resistance (AMR) Genotyping Panels Market?

The increasing occurrence of antimicrobial-resistant infections is projected to drive the growth of the antimicrobial resistance (AMR) genotyping panels market moving forward. These infections describe conditions caused by microorganisms, including bacteria, viruses, fungi, or parasites, which have adapted to withstand the effects of conventional antimicrobial drugs, making them more difficult to treat. Key factors contributing to increased antimicrobial resistance involve the excessive and improper use of antibiotics. These habits have expedited the development of resistant pathogens, thereby fueling the demand for AMR genotyping panels that can swiftly pinpoint resistance genes and inform precise antimicrobial treatment. For instance, the Centers for Disease Control and Prevention (CDC) reports that over 2.8 million antimicrobial-resistant infections occur annually in the US. Thus, the escalating prevalence of antimicrobial-resistant infections is a primary impetus for the expansion of the antimicrobial resistance (AMR) genotyping panels market.

What Segments Are Identified Within The Structure Of The Antimicrobial Resistance (AMR) Genotyping Panels Market?

The antimicrobial resistance (amr) genotyping panels market covered in this report is segmented –

1) By Product Type: Custom Panels, Pre-Designed Panels

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Microarray-Based, Next-Generation Sequencing (NSG)-Based, Other Technologies

3) By Application: Clinical Diagnostics, Research, Drug Development, Other Applications

4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-users

Subsegments:

1) By Custom Panels: Pathogen-Specific Panels, Resistance Gene-Focused Panels, Multiplex Detection Panels, Targeted Mutation Panels, Research Application Panels

2) By Pre-Designed Panels: Standardized Diagnostic Panels, Broad-Spectrum Resistance Panels, Disease-Specific Panels, Commercially Validated Panels, Ready-To-Use Screening Panels

Which Trends Are Expected To Influence The Antimicrobial Resistance (AMR) Genotyping Panels Market In The Upcoming Years?

Leading companies operating within the antimicrobial resistance (AMR) genotyping panels market are primarily focused on creating innovative products like multiplex PCR-based research assays. These assays enable the simultaneous detection of numerous pathogens and antibiotic resistance genes in a single test, thereby enhancing research efficiency and assisting in the faster identification of emerging resistance patterns. Multiplex PCR-based research assays specifically refer to molecular tests designed to amplify and detect multiple genetic targets simultaneously in one reaction to identify pathogens and antibiotic resistance genes. As an illustration, in September 2025, Molecular Designs, a US-based molecular diagnostics and research-assay company, introduced the Urogenital Microbiota with ABX 53 Simplicity Panel. This multiplex PCR-based research assay was developed to detect urinary pathogens and antibiotic resistance genes in a single test. The panel allows for the concurrent identification of 28 urogenital and urinary microbial targets (comprising 20 bacterial, 7 fungal, and 1 protozoan) along with 25 antibiotic-resistance gene markers. It offers same-day turnaround and is available in both 96-well and 384-well plate formats, with breakaway panels incorporated into the 96-well version to minimize waste.

Which Key Market Players Are Investing In Expansion And Innovation Within The Antimicrobial Resistance (AMR) Genotyping Panels Market?

Major companies operating in the antimicrobial resistance (amr) genotyping panels market are Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMérieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., OpGen Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-antimicrobial-resistance-amr-genotyping-panels-market-report

Which Regions Are Poised For Strategic Growth In The Antimicrobial Resistance (AMR) Genotyping Panels Market?

North America was the largest region in the antimicrobial resistance (AMR) genotyping panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance (amr) genotyping panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Antimicrobial Resistance (AMR) Genotyping Panels Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30196&type=smp

Browse Through More Reports Similar to the Global Antimicrobial Resistance (AMR) Genotyping Panels Market 2026, By The Business Research Company

Genotyping Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Antimicrobial Medical Device Coatings Market Report 2026

https://www.thebusinessresearchcompany.com/report/antimicrobial-medical-device-coatings-global-market-report

Multidrug Resistant Bacteria Market Report 2026

https://www.thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795